Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Parke

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 2010
ISCTM: Implementing phase 2 dose finding adaptive clinical trialsTom Parke
Statistics in Medicine|September 10, 2025
Using Confidence Distributions in Final and Interim Analyses for Single-Arm Studies or Platform Trials Consisting of Single-Arm StudiesGünter Heimann, Peter Jacko, Tom Parke
Statistical Methods in Medical Research|March 25, 2026
Randomization and allocation procedures for master protocol trials of single-arm studiesPeter Jacko, Günter Heimann, Tom Parke
Therapeutic Innovation & Regulatory Science|September 21, 2018
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific and Commercial ValueTom Parke, Vladimir Dragalin, Ibrahim Turkoz, et al.
Pharmaceutical Statistics|December 29, 2018
Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysisAaron Dane, Amy Spencer, Gerd Rosenkranz, et al.
Trials|March 22, 2024
Developing generic templates to shape the future for conducting integrated research platform trialsMadhavi Gidh-Jain, Tom Parke, Franz König, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Improving Oncology Clinical Programs by Use of Innovative Designs and Comparing Them via SimulationsOlga Marchenko, Joel Miller, Tom Parke, et al.
Trials|March 5, 2021
Systematic review of available software for multi-arm multi-stage and platform clinical trial designElias Laurin Meyer, Peter Mesenbrink, Tobias Mielke, et al.
Therapeutic Innovation & Regulatory Science|May 8, 2015
Advances in Statistical Approaches Oncology Drug DevelopmentAnastasia Ivanova, Gary L Rosner, Olga Marchenko, et al.
Journal of Biopharmaceutical Statistics|March 11, 2017
Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?Tom Parke, Olga Marchenko, Vladimir Anisimov, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 2010
ISCTM: Implementing phase 2 dose finding adaptive clinical trialsTom Parke
Statistics in Medicine|September 10, 2025
Using Confidence Distributions in Final and Interim Analyses for Single-Arm Studies or Platform Trials Consisting of Single-Arm StudiesGünter Heimann, Peter Jacko, Tom Parke
Statistical Methods in Medical Research|March 25, 2026
Randomization and allocation procedures for master protocol trials of single-arm studiesPeter Jacko, Günter Heimann, Tom Parke
Therapeutic Innovation & Regulatory Science|September 21, 2018
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific and Commercial ValueTom Parke, Vladimir Dragalin, Ibrahim Turkoz, et al.
Pharmaceutical Statistics|December 29, 2018
Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysisAaron Dane, Amy Spencer, Gerd Rosenkranz, et al.
Trials|March 22, 2024
Developing generic templates to shape the future for conducting integrated research platform trialsMadhavi Gidh-Jain, Tom Parke, Franz König, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Improving Oncology Clinical Programs by Use of Innovative Designs and Comparing Them via SimulationsOlga Marchenko, Joel Miller, Tom Parke, et al.
Trials|March 5, 2021
Systematic review of available software for multi-arm multi-stage and platform clinical trial designElias Laurin Meyer, Peter Mesenbrink, Tobias Mielke, et al.
Therapeutic Innovation & Regulatory Science|May 8, 2015
Advances in Statistical Approaches Oncology Drug DevelopmentAnastasia Ivanova, Gary L Rosner, Olga Marchenko, et al.
Journal of Biopharmaceutical Statistics|March 11, 2017
Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?Tom Parke, Olga Marchenko, Vladimir Anisimov, et al.
Pageof 2